Human medicines European public assessment report (EPAR): RoActemra, tocilizumab, Date of authorisation: 16/01/2009, Revision: 50, Status: Authorised
PSUSA/00002896/202509
Human medicines European public assessment report (EPAR): Lupkynis, voclosporin, Date of authorisation: 15/09/2022, Revision: 7, Status: Authorised
Reliance for post-authorisation changes: guidance for the pharmaceutical industry
Human medicines European public assessment report (EPAR): Lynparza, olaparib, Date of authorisation: 16/12/2014, Revision: 32, Status: Authorised
What we publish on medicines and when
Vaccines: concerns, questions and false claims
Human medicines European public assessment report (EPAR): Comirnaty, COVID-19 mRNA vaccine, Date of authorisation: 21/12/2020, Revision: 63, Status: Authorised
Performance enhancers - Scientific guideline
Product Management Service (PMS) – Frequently Asked Questions (FAQs)